Spironolactone and Fibrosis in Heart Failure Risk: Machine Learning Analysis of HOMAGE Trial Plasma Proteomics.

Saved in:
Bibliographic Details
Title: Spironolactone and Fibrosis in Heart Failure Risk: Machine Learning Analysis of HOMAGE Trial Plasma Proteomics.
Authors: Ravassa S; Laboratory of Heart Failure CIMA Universidad de Navarra and IdiSNA Pamplona Spain.; CIBERCV, Carlos III Institute of Health Madrid Spain., Girerd N; Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU De Nancy, F-CRIN INI-CRCT Université De Lorraine Nancy France., Edelman F; Department of Internal Medicine and Cardiology Campus Virchow Klinikum Charité University Medicine Berlin, Germany.; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin Berlin Germany., López B; Laboratory of Heart Failure CIMA Universidad de Navarra and IdiSNA Pamplona Spain.; CIBERCV, Carlos III Institute of Health Madrid Spain., Ferreira JP; Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU De Nancy, F-CRIN INI-CRCT Université De Lorraine Nancy France.; Cardiovascular Research and Development Center, Department of Surgery and Physiology Faculty of Medicine of the University of Porto Porto Portugal., Zurkan D; Department of Internal Medicine and Cardiology Campus Virchow Klinikum Charité University Medicine Berlin, Germany.; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin Berlin Germany., José GS; Laboratory of Heart Failure CIMA Universidad de Navarra and IdiSNA Pamplona Spain.; CIBERCV, Carlos III Institute of Health Madrid Spain., Latasa I; Laboratory of Heart Failure CIMA Universidad de Navarra and IdiSNA Pamplona Spain.; CIBERCV, Carlos III Institute of Health Madrid Spain., Pellicori P; School of Cardiovascular and Metabolic Health University of Glasgow Glasgow UK., Cosmi F; Department of Cardiology Cortona Hospital Arezzo Italy., Petutschnigg J; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin Berlin Germany.; Deutsches Herzzentrum der Charité, Klinik für Kardiologie Angiologie & Intensivmedizin, Augustenburger Platz 1 Berlin Germany.; Charité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin Berlin Germany., Heymans S; Department of Cardiology Maastricht University Medical Center Maastricht the Netherlands., Brunner-La Rocca HP; Department of Cardiology Maastricht University Medical Center Maastricht the Netherlands., Pieske B; Division of Cardiology, Department of Internal Medicine University Medicine Rostock Rostock Germany., Delles C; School of Cardiovascular and Metabolic Health University of Glasgow Glasgow UK., Clark AL; Castle Hill Hospital Hull University Teaching Hospitals NHS Trust Cottingham UK., Díez J; Laboratory of Heart Failure CIMA Universidad de Navarra and IdiSNA Pamplona Spain.; CIBERCV, Carlos III Institute of Health Madrid Spain., Zannad F; Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU De Nancy, F-CRIN INI-CRCT Université De Lorraine Nancy France., Cleland JGF; School of Cardiovascular and Metabolic Health University of Glasgow Glasgow UK., González A; Laboratory of Heart Failure CIMA Universidad de Navarra and IdiSNA Pamplona Spain.; CIBERCV, Carlos III Institute of Health Madrid Spain.; Department of Cardiology and Cardiac Surgery Clínica Universidad de Navarra Pamplona Spain.
Corporate Authors: HOMAGE Trial Committees and Investigators
Source: MedComm [MedComm (2020)] 2026 Feb 17; Vol. 7 (3), pp. e70634. Date of Electronic Publication: 2026 Feb 17 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: China NLM ID: 101769925 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-2663 (Electronic) Linking ISSN: 26882663 NLM ISO Abbreviation: MedComm (2020) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2688-2663
DOI:10.1002/mco2.70634